Skip to main content
Top
Published in: Indian Journal of Gastroenterology 5/2010

01-09-2010 | Original Article

Quality of life assessment of patients with chronic liver disease in eastern India using a Bengali translation chronic liver disease questionnaire

Authors: Irene Ray, Deep Dutta, Pallavi Basu, Binay K. De

Published in: Indian Journal of Gastroenterology | Issue 5/2010

Login to get access

Abstract

Aims

The aim of this study was to translate and validate chronic liver disease questionnaire (CLDQ) into Bengali using a standard protocol and use it to assess the impact of socioeconomic factors, etiology, disease severity and complications on the quality of life of patients.

Methods

Formal translation of CLDQ to Bengali was done. Cronbach’s alpha and test-retest was performed for reliability analysis. Patients with clinically stable chronic liver disease (CLD) without significant associated co-morbid states were administered Bengali CLDQ in the Liver Clinic. The clinical, biochemical and disease parameters were recorded for analysis.

Results

Bengali CLDQ was administered to 100 patients with CLD. Cronbach’s alpha of overall scores was 0.90 and test-retest correlation coefficient of average CLDQ was 0.86 (P < 0.001). Patients with history of decompensation (96.51 vs. 109.61; P = 0.039) and Child’s C status (92.24 vs. 105.71; P = 0.028) had significantly lower CLDQ scores. CLDQ scores showed a moderate inverse correlation with Child’s status (r = −0.35) and a poor correlation with MELD score (r = −0.09).

Conclusion

Bengali translation of CLDQ was found to be reliable. History of decompensation, Child’s C status was associated with worse CLDQ scores. Child’s status may have some role in predicting quality of life of patients with CLD. MELD score had poor predictability of quality of life.
Literature
1.
go back to reference WHO. Constitution of the World Health Organization. In: World Health Organization. Handbook of basic documents. 5th ed. Geneva: Palais des Nations; 1952. p. 3–20 WHO. Constitution of the World Health Organization. In: World Health Organization. Handbook of basic documents. 5th ed. Geneva: Palais des Nations; 1952. p. 3–20
2.
go back to reference Chochinov HM, Tataryn D, Clinch JJ, Dudgeon D. Will to live in the terminally ill. Lancet. 1999;354:816–9.PubMed Chochinov HM, Tataryn D, Clinch JJ, Dudgeon D. Will to live in the terminally ill. Lancet. 1999;354:816–9.PubMed
3.
go back to reference El-Dika S, Guyatt GH, Armstrong D, et al. The impact of illness in patients with moderate to severe gastro-esophageal reflux disease. BMC Gastroenterol. 2005;5:23.CrossRefPubMed El-Dika S, Guyatt GH, Armstrong D, et al. The impact of illness in patients with moderate to severe gastro-esophageal reflux disease. BMC Gastroenterol. 2005;5:23.CrossRefPubMed
4.
go back to reference Glise H, Wilklund I. Health-related quality of life and gastrointestinal disease. J Gastroenterol Hepatol. 2002;17(Suppl):S72–S84.CrossRefPubMed Glise H, Wilklund I. Health-related quality of life and gastrointestinal disease. J Gastroenterol Hepatol. 2002;17(Suppl):S72–S84.CrossRefPubMed
5.
go back to reference Kanwal F, Hays RD, Kilbourne AM, Dulai GS, Gralnek IM. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease? Am J Gastroenterol. 2004;99:1726–32.CrossRefPubMed Kanwal F, Hays RD, Kilbourne AM, Dulai GS, Gralnek IM. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease? Am J Gastroenterol. 2004;99:1726–32.CrossRefPubMed
6.
go back to reference Gralnek IM, Hays RD, Kilbourne A, et al. Development and evaluation of the liver disease quality of life instrument in persons with advanced, chronic liver disease—the LDQOL 1.0. Am J Gastroenterol. 2000;95:3552–65.PubMed Gralnek IM, Hays RD, Kilbourne A, et al. Development and evaluation of the liver disease quality of life instrument in persons with advanced, chronic liver disease—the LDQOL 1.0. Am J Gastroenterol. 2000;95:3552–65.PubMed
7.
go back to reference Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45:295–300.CrossRefPubMed Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45:295–300.CrossRefPubMed
8.
go back to reference Borgaonkar MR, Irvine EJ. Quality of life measurement in gastrointestinal and liver disorders. Gut. 2000;47:444–54.CrossRefPubMed Borgaonkar MR, Irvine EJ. Quality of life measurement in gastrointestinal and liver disorders. Gut. 2000;47:444–54.CrossRefPubMed
9.
go back to reference Younossi ZM, Boparai N, McCormick M, Price LL, Guyatt G. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol. 2001;96:579–83.CrossRefPubMed Younossi ZM, Boparai N, McCormick M, Price LL, Guyatt G. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol. 2001;96:579–83.CrossRefPubMed
10.
go back to reference Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120:170–78.CrossRefPubMed Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120:170–78.CrossRefPubMed
11.
go back to reference Chong CA, Gulamhussein A, Heathcote EJ, et al. Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol. 2003;98:630–38.CrossRefPubMed Chong CA, Gulamhussein A, Heathcote EJ, et al. Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol. 2003;98:630–38.CrossRefPubMed
12.
go back to reference Bianchi G, Loguercio C, Sgarbi D, et al. Reduced quality of life of patients with hepatocellular carcinoma. Dig Liver Dis. 2003;35:46–54.CrossRefPubMed Bianchi G, Loguercio C, Sgarbi D, et al. Reduced quality of life of patients with hepatocellular carcinoma. Dig Liver Dis. 2003;35:46–54.CrossRefPubMed
13.
go back to reference Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001;96:2199–205.CrossRefPubMed Younossi ZM, Boparai N, Price LL, Kiwi ML, McCormick M, Guyatt G. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001;96:2199–205.CrossRefPubMed
14.
go back to reference Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci. 2003;48:1622–6.CrossRefPubMed Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci. 2003;48:1622–6.CrossRefPubMed
15.
go back to reference Cordoba J, Flavia M, Jacas C, et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol. 2003;39:231–8.CrossRefPubMed Cordoba J, Flavia M, Jacas C, et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol. 2003;39:231–8.CrossRefPubMed
16.
go back to reference Sobhonslidsuk A, Silpakit C, Kongsakon R, Satitpornkul P, Sripetch C. Chronic liver disease questionnaire: translation and validation in Thais. World J Gastroenterol. 2004;10:1954–7.PubMed Sobhonslidsuk A, Silpakit C, Kongsakon R, Satitpornkul P, Sripetch C. Chronic liver disease questionnaire: translation and validation in Thais. World J Gastroenterol. 2004;10:1954–7.PubMed
17.
go back to reference Ferrer M, Córdoba J, Garin O, et al. Validity of the Spanish version of the chronic liver disease questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl. 2006;12:95–104.CrossRefPubMed Ferrer M, Córdoba J, Garin O, et al. Validity of the Spanish version of the chronic liver disease questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transpl. 2006;12:95–104.CrossRefPubMed
18.
go back to reference Zuberi BF, Memon AR, Afsar S, Qadeer R, Kumar R. Correlation of quality of life in patients of cirrhosis of liver with etiology and disease severity using disease-specific quality of life questionnaire. J Ayub Med Coll Abottabad. 2007;19:7–11. Zuberi BF, Memon AR, Afsar S, Qadeer R, Kumar R. Correlation of quality of life in patients of cirrhosis of liver with etiology and disease severity using disease-specific quality of life questionnaire. J Ayub Med Coll Abottabad. 2007;19:7–11.
19.
go back to reference Hauser W, Schnur M, Steder-Neukamm U, Muthny FA, Grandt D. Validation of the German version of the chronic liver disease questionnaire. Eur J Gastroenterol Hepatol. 2004;16:599–606.CrossRefPubMed Hauser W, Schnur M, Steder-Neukamm U, Muthny FA, Grandt D. Validation of the German version of the chronic liver disease questionnaire. Eur J Gastroenterol Hepatol. 2004;16:599–606.CrossRefPubMed
20.
go back to reference Tiwari R, Aggarwal A, Devi P. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency viruses amongst drug users in Amritsar. Indian J Med Microbiol. 2006;24:151–2.CrossRefPubMed Tiwari R, Aggarwal A, Devi P. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency viruses amongst drug users in Amritsar. Indian J Med Microbiol. 2006;24:151–2.CrossRefPubMed
21.
go back to reference Kawabata K, Xu K, Carrin G. Preventing impoverishment through protection against catastrophic health expenditure. Bull World Health Organ. 2002;80:612.PubMed Kawabata K, Xu K, Carrin G. Preventing impoverishment through protection against catastrophic health expenditure. Bull World Health Organ. 2002;80:612.PubMed
22.
go back to reference Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11:193–205.CrossRef Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11:193–205.CrossRef
23.
24.
25.
go back to reference Bergner M, Bobbit RA, Pollard WE, et al. The sickness impact profile: validation of a health status measure. Med Care. 1976;14:57–67.CrossRefPubMed Bergner M, Bobbit RA, Pollard WE, et al. The sickness impact profile: validation of a health status measure. Med Care. 1976;14:57–67.CrossRefPubMed
26.
go back to reference McSweeny AJ, Creer TL. Health-related quality-of-life assessment in medical care. Dis Mon. 1995;41:1–7l.PubMed McSweeny AJ, Creer TL. Health-related quality-of-life assessment in medical care. Dis Mon. 1995;41:1–7l.PubMed
27.
go back to reference Bush JW. General health policy model/quality of well-being (QWB) scale. In: Wenger NK, Mattson ME, Furberg CD, et al. eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: LeJacq; 1984. p. 189–99. Bush JW. General health policy model/quality of well-being (QWB) scale. In: Wenger NK, Mattson ME, Furberg CD, et al. eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: LeJacq; 1984. p. 189–99.
28.
go back to reference Andresen EM, Rothenberg BM, Kaplan RM. Performance of a self-administered mailed version of the quality of well-being (QWB-SA) questionnaire among older adults. Med Care. 1998;36:1349–60.CrossRefPubMed Andresen EM, Rothenberg BM, Kaplan RM. Performance of a self-administered mailed version of the quality of well-being (QWB-SA) questionnaire among older adults. Med Care. 1998;36:1349–60.CrossRefPubMed
29.
go back to reference Stewart AL, Hays RD, Ware JE Jr. The MOS short form general health survey. Reliability and validity in a patient population. Med Care. 1988;26:724–35.CrossRefPubMed Stewart AL, Hays RD, Ware JE Jr. The MOS short form general health survey. Reliability and validity in a patient population. Med Care. 1988;26:724–35.CrossRefPubMed
30.
go back to reference Tarlov AR, Ware JE Jr, Greenfield S, et al. The medical outcomes study: an application of methods for monitoring the effects of medical care. JAMA. 1989;262:925–30.CrossRefPubMed Tarlov AR, Ware JE Jr, Greenfield S, et al. The medical outcomes study: an application of methods for monitoring the effects of medical care. JAMA. 1989;262:925–30.CrossRefPubMed
31.
go back to reference Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRefPubMed Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRefPubMed
32.
go back to reference Kanwal F, Gralnek IM, Hays RD, et al. Spiegel BM Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol. 2009;7:793–9.CrossRefPubMed Kanwal F, Gralnek IM, Hays RD, et al. Spiegel BM Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol. 2009;7:793–9.CrossRefPubMed
33.
go back to reference Younossi Z, Kallman J, Kincaid J. The effects of HCV infection and management on health-related quality of life. Hepatology. 2007;45:806–16.CrossRefPubMed Younossi Z, Kallman J, Kincaid J. The effects of HCV infection and management on health-related quality of life. Hepatology. 2007;45:806–16.CrossRefPubMed
34.
go back to reference Marcellin P, Lau GK, Zeuzem S, et al. Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a. Liver Int. 2008;28:477–85.CrossRefPubMed Marcellin P, Lau GK, Zeuzem S, et al. Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a. Liver Int. 2008;28:477–85.CrossRefPubMed
Metadata
Title
Quality of life assessment of patients with chronic liver disease in eastern India using a Bengali translation chronic liver disease questionnaire
Authors
Irene Ray
Deep Dutta
Pallavi Basu
Binay K. De
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Indian Journal of Gastroenterology / Issue 5/2010
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-010-0036-x

Other articles of this Issue 5/2010

Indian Journal of Gastroenterology 5/2010 Go to the issue

Gastroenterology Research

Gastroenterology elsewhere

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.